Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Fludarabine may be an effective treatment for graft-versus-host disease caused by
bone marrow transplantation.
PURPOSE: Phase I/II trial to study the effectiveness of fludarabine in treating patients who
have chronic graft-versus-host disease that has not responded to steroid therapy.